disruptive industries, but one important area they may not yet fully appreciate is nanotechnology. Nanotech is used today in awide variety of businesses, ranging from agriculture, to biotech, to defense, to energy and semiconductors. With this innovation, materials can be made stronger, lighter, more durable and more reactive, helping to reduce costs and increase productivity.”
The TYNE ETF aspires to track the investment outcomes of the S&P Kensho Extended Nanotechnology Index, before fees and costs. The S&P Kensho Extended Nanotechnology Index monitors the operation of publicly traded companies in the United States that are engaged in the creation and/or manipulation of matter at the molecular level through the provision of one or more of the four product or service categories: fabrication and manufacturing processes, measurement and simulation, materials, and delivery systems.
This nanotech ETF ($TYNE) allows investors to get exposure to nanotech stocks and the nanotech industry by investing in the US-listed nanotech companies including Moderna, Inc. (MRNA), Thermo Fisher Scientific (TMO), Nano Dimension Ltd. ADR (NNDM), BionTech SE (BNTX), Beam Therapeutics Inc. (BEAM), and others.
The 29 components had a median total market value of $4 billion until November 12, 2021, with total market capitalizations ranging from $98 million to $250 billion, with a concentration in the medical and information technology industries.
